Mettler-Toledo International Inc at JPMorgan Healthcare Conference Summary - Thomson StreetEvents

Mettler-Toledo International Inc at JPMorgan Healthcare Conference Summary

Mettler-Toledo International Inc at JPMorgan Healthcare Conference Summary - Thomson StreetEvents
Mettler-Toledo International Inc at JPMorgan Healthcare Conference Summary
Published Jan 14, 2025
9 pages (4952 words) — Published Jan 14, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of MTD.N presentation 14-Jan-25 11:45pm GMT

  
Brief Excerpt:

...A. We generated around $3.8 billion in revenue and a significant majority of our sales are in segments in which we are the global market leader. B. We serve attractive end markets and estimate that over 70% of our sales are to attractive growth markets of pharma and biopharma, food manufacturers, and specialty chemicals. C. Now let's briefly review our product offering, starting with our laboratory instruments, which represent more than 55% of our total sales. D. Our laboratory instruments are also used -- also very important in QA and QC labs, and we provide these customers approximately 40% of the bench instruments that are typically found in an analytical quality control lab. E. This next slide is an overview of several of our industrial products and solutions which represents about 40% of our total sales. F. The largest portion of industrial is our core industrial business, which represents approximately 25% of our total sales and represents our scales, weigh modules, terminals, and...

  
Report Type:

Brief

Source:
Company:
Mettler-Toledo International Inc
Ticker
MTD.N
Time
11:45pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : So I figured maybe just given your guys' portfolio exposures and some of the equipment exposures there. First question, just on budget flush trends. I think that's a common theme that we've been hearing from some of your peers in the last few days. So I appreciate we'll get full numbers in a few weeks here. But qualitatively, any comments on if you guys saw a budget flush throughout 4Q? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Yes. Maybe digging into that last point on the recovery from an end market, can you unpack that for us a little bit as we look throughout 2025. Should we expect this to be a more linear recovery? Should it be more hockey sticks? I have a follow-up question on 1Q and some logistics. But maybe just from an end market perspective, walk us through the assumptions there.


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Then my follow-up just related to this logistics issue. If we look back at JPMorgan last year, I think that dominated a lot of the airtime, hopefully, this is kind of the last quarter that we're talking about it here. But walk us through, obviously, that becomes a headwind to growth and margins this quarter, as you guys explained. So walk us through some of the math there on how we should see that impacting both top line and margins in 1Q. And then maybe if we just exclude that, again, the cadence from like 1Q into 2Q kind of like you spoke about there.


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Great. That's helpful. Maybe just on pricing. So your guidance assumes 2% pricing contribution this year. Can you walk us through your pricing power across various products throughout the portfolio, and kind of what gives you that resiliency and confidence that you're going to hit 2% pricing contribution in '25?


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Great. And then just talking about the equipment and instrumentation exposure here. Obviously, spending has been soft from a CapEx budget standpoint throughout 2024. So can you spend a minute talking about if you've seen any green shoots in equipment and instrumentation spending recently? And then what are you really assuming for that part of your portfolio in terms of growth in 2025?


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : That's helpful. Maybe shifting more towards your long-term outlook. Your LRP assumes 6% local currency growth. Just given how volatile and kind of dynamic the last few years have been, can you talk about how are you still thinking about that 6% long-term growth rate? Is that still achievable? And really, what gives you the confidence to be able to hit that guide?


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Maybe alongside that, I think some of this opportunity on reshoring and onshoring could be as a result of tariffs as well. So maybe segue into the tariff exposure here. Can you walk us through your manufacturing exposure? I know you mentioned some of it in China on the presentation. But across China, Canada, Mexico, how are you guys exposed there? How is Mettler thinking about the potential impact from tariffs?


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Helpful color. Maybe just shifting over to China then. I think China also has been a very dynamic region that a lot of investors have questions on in the room. So just on the topic of China stimulus, can you walk us through how are you guys seeing Mettler impacted from China stimulus? Obviously, we have some of the equipment specific stimulus. It seems like it's a little more towards some of those higher dollar ticket items. We also brought economic stimulus as well. So walk me through what are the potential impacts to Mettler there? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Maybe on that long-term China assumption. Can you walk us through what are some of the drivers there? Also alongside this local competition gets brought up a lot for Mettler-Toledo, just given the vast magnitude of competitors that you have there. So has anything changed on the local competition front? Or how are you guys thinking about that piece?


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Perfect. Then just in terms of new product launches, you mentioned that during your presentation and prepared remarks as well. So can you walk us through some of the themes that you're prioritizing when it comes to R&D and innovation over the next one to three years? And what we can expect from a pipeline perspective there? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.


Question: Rachel Vatnsdal Olson - JPMorgan - Analyst : Perfect. And with that, we are out of time. So thank you so much for joining us today, and thank you to everyone in the room as well.

Table Of Contents

Mettler-Toledo International Inc Q1 2025 Earnings Call Summary – 2025-05-02 – US$ 106.00 – Edited Brief of MTD.N earnings conference call or presentation 2-May-25 12:30pm GMT

Mettler-Toledo International Inc Q1 2025 Earnings Call Transcript – 2025-05-02 – US$ 106.00 – Edited Transcript of MTD.N earnings conference call or presentation 2-May-25 12:30pm GMT

Mettler-Toledo International Inc Q4 2024 Earnings Call Summary – 2025-02-07 – US$ 54.00 – Edited Brief of MTD.N earnings conference call or presentation 7-Feb-25 1:30pm GMT

Mettler-Toledo International Inc Q4 2024 Earnings Call Transcript – 2025-02-07 – US$ 54.00 – Edited Transcript of MTD.N earnings conference call or presentation 7-Feb-25 1:30pm GMT

Mettler-Toledo International Inc at JPMorgan Healthcare Conference Transcript – 2025-01-14 – US$ 54.00 – Edited Transcript of MTD.N presentation 14-Jan-25 11:45pm GMT

Mettler-Toledo International Inc at Evercore ISI HealthCONx Conference Summary – 2024-12-04 – US$ 54.00 – Edited Brief of MTD.N presentation 4-Dec-24 2:10pm GMT

Mettler-Toledo International Inc at Evercore ISI HealthCONx Conference Transcript – 2024-12-04 – US$ 54.00 – Edited Transcript of MTD.N presentation 4-Dec-24 2:10pm GMT

Mettler-Toledo International Inc at Stifel Healthcare Conference Summary – 2024-11-19 – US$ 54.00 – Edited Brief of MTD.N presentation 19-Nov-24 6:15pm GMT

Mettler-Toledo International Inc at Stifel Healthcare Conference Transcript – 2024-11-19 – US$ 54.00 – Edited Transcript of MTD.N presentation 19-Nov-24 6:15pm GMT

Mettler-Toledo International Inc Q3 2024 Earnings Call Summary – 2024-11-08 – US$ 54.00 – Edited Brief of MTD.N earnings conference call or presentation 8-Nov-24 1:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Mettler-Toledo International Inc at JPMorgan Healthcare Conference Summary" Jan 14, 2025. Alacra Store. May 06, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Mettler-Toledo-International-Inc-at-JPMorgan-Healthcare-Conference-B16214143>
  
APA:
Thomson StreetEvents. (2025). Mettler-Toledo International Inc at JPMorgan Healthcare Conference Summary Jan 14, 2025. New York, NY: Alacra Store. Retrieved May 06, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Mettler-Toledo-International-Inc-at-JPMorgan-Healthcare-Conference-B16214143>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.